• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization of 5-fluorouracil microspheres for colonic delivery.用于结肠给药的5-氟尿嘧啶微球的特性研究
AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.
2
Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.用于结肠靶向的5-氟尿嘧啶的聚丙烯酸树脂包衣果胶微球。
AAPS PharmSciTech. 2007 Feb 16;8(1):12. doi: 10.1208/pt0801012.
3
Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.用于结肠靶向给药的包衣型5-氟尿嘧啶葡聚糖微球
Drug Deliv. 2016;23(1):328-37. doi: 10.3109/10717544.2014.913733. Epub 2014 May 20.
4
Microsphere design for the colonic delivery of 5-fluorouracil.用于5-氟尿嘧啶结肠递送的微球设计
J Control Release. 2003 Jul 31;90(3):313-22. doi: 10.1016/s0168-3659(03)00195-0.
5
Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.果胶/乙基纤维素作为结肠靶向给药的薄膜包衣:以5-氟尿嘧啶微丸为例的制备及体外评价
PDA J Pharm Sci Technol. 2007 Mar-Apr;61(2):121-30.
6
Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.载有萘普生钠的 Eudragit S-100 包衣海藻酸钠微球的制备、优化及体外评价。
Acta Pharm. 2012 Dec;62(4):529-45. doi: 10.2478/v10007-012-0034-x.
7
Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.通过混合膜包衣单位系统对 5-氟尿嘧啶进行结肠递药的定制。
Acta Pharm. 2011 Sep 1;61(3):343-51. doi: 10.2478/v10007-011-0023-5.
8
Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.羟丙基甲基纤维素压制包衣片中5-氟尿嘧啶释放特性的研究
Pharm Dev Technol. 2007;12(2):203-10. doi: 10.1080/10837450601168722.
9
Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.小麦胚芽凝集素偶联壳聚糖-海藻酸钠微球用于 5-FU 的局部结肠递药:制备与体外评价。
Int J Pharm. 2009 Nov 3;381(2):166-75. doi: 10.1016/j.ijpharm.2009.06.037. Epub 2009 Jul 4.
10
Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.5-氟尿嘧啶的结肠给药:体外评价
Int J Pharm. 2004 Jan 9;269(1):101-8. doi: 10.1016/j.ijpharm.2003.09.036.

引用本文的文献

1
Solid lipid Lyo-Nanosuspension: A promising stabilized oral delivery system for the antihyperglycemic extract of mistletoe .固体脂质冻干纳米混悬液:一种用于槲寄生抗高血糖提取物的有前景的稳定口服给药系统。
Saudi Pharm J. 2023 Aug;31(8):101689. doi: 10.1016/j.jsps.2023.06.022. Epub 2023 Jun 26.
2
Smart Pellets for Controlled Delivery of 5-Fluorouracil.智能微丸控释 5-氟尿嘧啶
Molecules. 2022 Dec 30;28(1):306. doi: 10.3390/molecules28010306.
3
Preparation and Characteristics of Alginate Microparticles for Food, Pharmaceutical and Cosmetic Applications.用于食品、制药和化妆品应用的海藻酸盐微粒的制备与特性
Polymers (Basel). 2022 Sep 14;14(18):3834. doi: 10.3390/polym14183834.
4
Oxidation of Drugs during Drug Product Development: Problems and Solutions.药品研发过程中药物的氧化:问题与解决方案
Pharmaceutics. 2022 Jan 29;14(2):325. doi: 10.3390/pharmaceutics14020325.
5
Formulation, Optimization, and Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior.载有沙格列汀的脂球体的配方优化及评价:改善药代动力学行为。
Biomed Res Int. 2021 Oct 20;2021:3849093. doi: 10.1155/2021/3849093. eCollection 2021.
6
Formulation and optimisation of lamivudine-loaded Eudragit S 100 polymer-coated pectin microspheres for colon-specific delivery.载拉米夫定的 Eudragit S 100 聚合物包被果胶微球的配方与优化及其结肠定位给药。
IET Nanobiotechnol. 2021 Feb;15(1):90-99. doi: 10.1049/nbt2.12010. Epub 2021 Feb 2.
7
Evaluation of Low Molecular Weight Cross Linked Chitosan Nanoparticles, to Enhance the Bioavailability of 5-Flourouracil.低分子量交联壳聚糖纳米颗粒对提高5-氟尿嘧啶生物利用度的评估
Dose Response. 2021 Jul 28;19(2):15593258211025353. doi: 10.1177/15593258211025353. eCollection 2021 Apr-Jun.
8
Hydrogels Based on Poly(Ether-Ester)s as Highly Controlled 5-Fluorouracil Delivery Systems-Synthesis and Characterization.基于聚(醚-酯)的水凝胶作为高度可控的5-氟尿嘧啶递送系统——合成与表征
Materials (Basel). 2020 Dec 28;14(1):98. doi: 10.3390/ma14010098.
9
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.负载5-氟尿嘧啶的聚氰基丙烯酸丁酯和聚己内酯纳米颗粒增强了该药物对实验性结肠癌的细胞毒性作用。
AAPS J. 2015 Jul;17(4):918-29. doi: 10.1208/s12248-015-9761-5. Epub 2015 Apr 17.
10
Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.新型载5-氟尿嘧啶胃靶向性位点特异性中空漂浮微球的研制与表征
ScientificWorldJournal. 2014;2014:705259. doi: 10.1155/2014/705259. Epub 2014 Oct 14.

本文引用的文献

1
The application and mechanisms of polyethylene glycol 8000 on stabilizing lactate dehydrogenase during lyophilization.聚乙二醇8000在冻干过程中稳定乳酸脱氢酶的应用及机制
PDA J Pharm Sci Technol. 2004 Jul-Aug;58(4):192-202.
2
Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder.聚乙二醇诱导的α-2a干扰素沉淀,随后进行真空干燥:一种获得干燥、稳定粉末的新工艺的开发。
AAPS PharmSci. 2004 Jan 26;6(1):E4. doi: 10.1208/ps060104.
3
Peroxide formation in polysorbate 80 and protein stability.聚山梨醇酯80中过氧化物的形成与蛋白质稳定性
J Pharm Sci. 2002 Oct;91(10):2252-64. doi: 10.1002/jps.10216.
4
PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques.细胞因子及其他治疗性蛋白质和肽的聚乙二醇化:偶联技术生物学优化的重要性
Int J Hematol. 1998 Jul;68(1):1-18. doi: 10.1016/s0925-5710(98)00039-5.
5
Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor.
PDA J Pharm Sci Technol. 1996 May-Jun;50(3):163-71.
6
Peroxide accumulation in detergents.洗涤剂中过氧化物的积累。
J Biochem Biophys Methods. 1994 Jul;29(1):77-81. doi: 10.1016/0165-022x(94)90058-2.
7
Protein crystallization: the growth of large-scale single crystals.
Methods Enzymol. 1984;104:370-81. doi: 10.1016/s0076-6879(84)04104-5.
8
Degradation of fenprostalene in polyethylene glycol 400 solution.
J Pharm Sci. 1984 Oct;73(10):1414-7. doi: 10.1002/jps.2600731023.
9
A stability study of chloramphenicol in topical formulations.
J Pharm Pharmacol. 1970 Aug;22(8):607-11. doi: 10.1111/j.2042-7158.1970.tb10577.x.
10
Use of polyethylene glycol in the crystallization of macromolecules.
Methods Enzymol. 1985;114:120-5. doi: 10.1016/0076-6879(85)14008-5.

用于结肠给药的5-氟尿嘧啶微球的特性研究

Characterization of 5-fluorouracil microspheres for colonic delivery.

作者信息

Rahman Ziyaur, Kohli Kanchan, Khar Roop K, Ali Mushir, Charoo Naseem A, Shamsher Areeg A A

机构信息

Department of Pharmaceutics, F/O Pharmacy, Hamdard University, New Delhi-110063 India.

出版信息

AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.

DOI:10.1208/pt070247
PMID:16796364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750504/
Abstract

The purpose of this investigation was to prepare and evaluate the colon-specific microspheres of 5-fluorouracil for the treatment of colon cancer. Core microspheres of alginate were prepared by the modified emulsification method in liquid paraffin and by cross-linking with calcium chloride. The core microspheres were coated with Eudragit S-100 by the solvent evaporation technique to prevent drug release in the stomach and small intestine. The microspheres were characterized by shape, size, surface morphology, size distribution, incorporation efficiency, and in vitro drug release studies. The outer surfaces of the core and coated microspheres, which were spherical in shape, were rough and smooth, respectively. The size of the core microspheres ranged from 22 to 55 microm, and the size of the coated microspheres ranged from 103 to 185 microm. The core microspheres sustained the drug release for 10 hours. The release studies of coated microspheres were performed in a pH progression medium mimicking the conditions of the gastrointestinal tract. Release was sustained for up to 20 hours in formulations with core microspheres to a Eudragit S-100 coat ratio of 1:7, and there were no changes in the size, shape, drug content, differential scanning calorimetry thermogram, and in vitro drug release after storage at 40 degrees C/75% relative humidity for 6 months.

摘要

本研究的目的是制备并评估用于治疗结肠癌的5-氟尿嘧啶结肠靶向微球。通过改良乳化法在液体石蜡中制备藻酸盐核微球,并与氯化钙交联。采用溶剂蒸发技术用Eudragit S-100包衣核微球,以防止药物在胃和小肠中释放。通过形状、大小、表面形态、粒径分布、包封率和体外药物释放研究对微球进行表征。核微球和包衣微球的外表面分别为粗糙和光滑的球形。核微球的大小范围为22至55微米,包衣微球的大小范围为103至185微米。核微球可持续释放药物10小时。在模拟胃肠道条件的pH梯度介质中进行包衣微球的释放研究。在核微球与Eudragit S-100包衣比例为1:7的制剂中,释放可持续长达20小时,在40℃/75%相对湿度下储存6个月后,微球的大小、形状、药物含量、差示扫描量热图谱和体外药物释放均无变化。